Drug Shortage Report for ROSUVASTATIN

Last updated on 2020-08-28 History
Report ID 123152
Drug Identification Number 02411628
Brand name ROSUVASTATIN
Common or Proper name ROSUVASTATIN
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) ROSUVASTATIN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-12-18
Actual start date
Estimated end date 2021-04-02
Actual end date
Shortage status Anticipated shortage
Updated date 2020-08-28
Company comments
Health Canada comments
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-08-28 French Compare
v1 2020-08-28 English Compare